Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVF/ICSI efficacy comparison of dydrogesterone versus medroxyprogesterone acetate in women with polycystic ovary syndrome
ChiCTR1800016284Phase 4Recruiting
- Sponsor
- Shanghai First Maternal and Infant Health Hospital
- Start
- May 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dydrogesterone, medroxyprogesterone acetate and human menopausal gonadotrophin in polycystic ovary syndrome (PCOS) and infertility (2 arms), sponsored by Shanghai First Maternal and Infant Health Hospital. Primary endpoints: FSH, LH and 8 more. Started May 2018; status: recruiting.
02
Drugs
dydrogesteronemedroxyprogesterone acetatehuman menopausal gonadotrophin
03
Conditions
polycystic ovary syndrome (PCOS)infertility
Beyond the preview
Go deeper on ChiCTR1800016284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016284.